Report Details:
15 Companies Covered
90 Pages
Pune, India, June 2023 /MRFR Press Release/- Market Research Future published a half-cooked research report on global ovarian cysts market.
Key Highlights on Ovarian Cysts Market:
The global ovarian cysts market is expected to grow at an approximate CAGR of 23.52 % during the forecast period (2025 - 2034) to hit USD 6.13 (USD Billion) by 2030.
Ovarian cysts are closed, sac-like structures filled with a liquid or semisolid substance within the ovary.
The formation of ovarian cysts in ovulating females is common. However, if the formation of ovarian cysts occurs after the menopause, then a high risk for the development of the ovarian cancer is suspected. Increasing prevalence of the ovarian cysts is likely to drive the market growth during the forecast period. According to a study published in the Journal of Clinical Research in Paediatric Endocrinology in 2017, the frequency of ovarian cysts is about 1.8% in children aged between 5-9 years and 18.8% in those who aged between 10-18 years. Moreover, it is estimated that with the onset of adolescence and increasing age, the frequency of ovarian cysts increases and ranges in between 3.8%-31.3%. Moreover, rising healthcare expenditures, increasing awareness about woman health are projected to boost the market growth during the forecast period. However, lack of awareness and low per capita healthcare expenditure in the developing countries may hamper the market growth.
Segmentation
The global ovarian cysts market is segmented on the basis of type, diagnosis, treatment, and end users.
On the basis of the type, the market is segmented into functional cysts, non-functional cysts, and others. The functional cysts segment, by type, is sub-segmented into the follicular cyst, corpus luteum cyst, and others. The non-functional cysts segment, by type, is sub-segmented into dermoid cysts, cystadenomas, endometriomas, and others.
On the basis of diagnosis, the market is segmented into imaging, CA-125 blood test, laparoscopy, and others. The imaging segment is sub-segmented into CT scan, MRI, ultrasound, and others.
On the basis of the treatment, the market is segmented into medication, polycystic ovary syndrome (PCOS) drugs, pain relievers, surgery, and others. The pain relievers segment is sub-segmented into acetaminophen, non-steroidal anti-inflammatory drugs, opioids, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.
Regional Analysis
America dominates the global ovarian cysts market owing to a well-developed healthcare sector and huge patient population. Apart from this, changing lifestyle, and increasing healthcare expenditure have boosted the growth of the market in America. Moreover, the presence of developed economies like the U.S. and Canada within the regional boundaries of the Americas fuels the market growth.
Europe is the second largest ovarian cysts market, which is followed by Asia Pacific. Availability of funds for research, increasing healthcare expenditures, well-developed healthcare sector and government support for research & development are projected to drive the market growth during the forecasted period.
Asia Pacific is the fastest growing region in global the market due to the presence of a huge patient population and continuously developing economies like India and China. Moreover, the presence of huge opportunities within the region fuels the market growth.
On the other hand, the Middle East & Africa holds the least share of the global ovarian cysts market due to the presence of poor economies and stringent government policies, especially, in the African region. Majority of the market in this region is held by the Middle East due to the well-developed healthcare sector and huge healthcare expenditure.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Ovarian Cysts Market Research Report
Key Players
Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (The Middle East & Africa), Quest Diagnostics Incorporated. (U.S.), Novartis AG (Europe), General Electric Company (Europe), Merck & Co., Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic (U.S.), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune - 411028
Maharashtra, India
+1 646 845 9312